Who we are

Managed by Brandon Capital, Brandon BioCatalyst supports the development and commercialisation of early-stage biomedical discoveries originating from member research organisations, providing both capital and expertise to guide the successful development of new therapies.

Brandon BioCatalyst is a unique collaboration of investors, CSL, government and more than 50 leading medical research institutes and hospitals united by a single purpose: generating cutting edge, next generation medical therapies and technologies to improve health and save lives.

    Technologies, expertise

    50+ Medical research institutes and hospitals

    Operational support

    ACT Government
    NSW Government Health
    Government of South Australia
    Queensland Government
    Victorian Government
    Western Australian Government
    Ministry of Business, Innovation & Employment (MBIE) NZ

    Management

    Brandon Capital

    Independent Governance
    Investors

    Australian Government
    Australian Super
    Hesta
    Host Plus
    TelstraSuper
    CSL

Members

Institute
The Burnet Institute

The Burnet Institute is an independent, not‐for‐profit Australian organization that is unique in its approach of linking medical research with public health action to address many of the major health problems affecting disadvantaged communities. This approach allows us to develop innovative health solutions ranging from the highly technological through to those that are community-based.

View
Institute
Harry Perkins Institute of Medical Research

Since 1998, the Harry Perkins Institute of Medical Research has grown to become one of the nation’s leading adult medical research centres, where a close-knit team of more than 400 research and trial staff work together to defeat the major diseases that impact our community. Our teams investigate a wide range of diseases, with a strong focus on cancer, cardiovascular disease, diabetes and neurogenetic diseases. Our world-class scientists, doctors and researchers are inspired to pursue vital research initiatives to build a healthier future for everyone.

View
Institute
Peter MacCallum Cancer Centre

Peter Mac is one of the world’s leading cancer research, education and treatment centres globally and is Australia’s only public hospital solely dedicated to caring for people affected by cancer. There are over 2,500 staff, including more than 600 laboratory and clinical researchers, all focused on providing better treatments, better care and potential cures for cancer.

View

Government Partners

Investors

Brandon BioCatalyst's investors are AustralianSuper, HESTA, HOSTPLUS, TelstraSuper, CSL and the Australian Government under its IIF and BTF programs.

Brandon Capital

Brandon Capital manages Brandon BioCatalyst, providing seed and venture capital investment to support the development and international growth of Australian and New Zealand life science companies.

Brandon Capital website